Allakos Inc reports results for the quarter ended in December - Earnings Summary

Allakos

14/03/2024 21:25

* Allakos Inc  ALLK.OQ  reported a quarterly adjusted loss
of 71
cents​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -50
cents.  The mean expectation of nine analysts for the quarter
was for a loss of 47 cents per share. Wall Street expected
results to range from -56 cents to -25 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Allakos Inc's reported EPS for the quarter was a loss
of 71
cents​.
    * The company reported a quarterly loss of $62.55 million.
    * Allakos Inc shares had fallen by 48.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Allakos Inc is
$2.00 
This summary was machine generated from LSEG data March 14 at
09:25 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.47          -0.71          Missed
 Sep. 30 2023      -0.45          -0.52          Missed
 Jun. 30 2023      -0.48          -0.41          Beat
 Mar. 31 2023      -0.49          -0.49          Met